Efficacy of Aspergillus galactomannan-directed preemptive therapy for the prevention of invasive aspergillosis in organ transplant recipients.
Marino
I R
IR
Panarello
G
G
Singh
N
N
D000935:Antifungal Agents / Q000627:therapeutic use; D001228:Aspergillosis / Q000209:etiology / Q000517:prevention & control*; D001230:Aspergillus / Q000187:drug effects; D006801:Humans; D009181:Mycoses / Q000175:diagnosis / Q000453:epidemiology; D016377:Organ Transplantation / Q000009:adverse effects*; D013997:Time Factors
D000935:Antifungal Agents